Postoperative radiotherapy with concomitant temozolomide plus anlotinib for newly diagnosed glioblastoma: Study protocol for a multicenter, double-blind, randomized phase II trial

MLA

Yuanyuan Chen, et al. “Postoperative Radiotherapy with Concomitant Temozolomide plus Anlotinib for Newly Diagnosed Glioblastoma: Study Protocol for a Multicenter, Double-Blind, Randomized Phase II Trial.” Glioma, vol. 5, no. 2, Jan. 2022, pp. 69–76. EBSCOhost, https://doi.org/10.4103/glioma.glioma_17_22.

APA

Yuanyuan Chen, Baiqiang Dong, Guihong Liu, Pengfei Sun, Meihua Li, Xuejun Yang, Shiyu Feng, Liang Wang, Yonghong Hua, Ming Zhao, Yanhui Liu, Juntao Ran, Li Qiao, Xueguan Lu, Hao Jiang, Deqiang Mao, Junxin Wu, Xianming Li, Wei Zheng, … Zhong-ping Chen. (2022). Postoperative radiotherapy with concomitant temozolomide plus anlotinib for newly diagnosed glioblastoma: Study protocol for a multicenter, double-blind, randomized phase II trial. Glioma, 5(2), 69–76. https://doi.org/10.4103/glioma.glioma_17_22

Chicago

Yuanyuan Chen, Baiqiang Dong, Guihong Liu, Pengfei Sun, Meihua Li, Xuejun Yang, Shiyu Feng, et al. 2022. “Postoperative Radiotherapy with Concomitant Temozolomide plus Anlotinib for Newly Diagnosed Glioblastoma: Study Protocol for a Multicenter, Double-Blind, Randomized Phase II Trial.” Glioma 5 (2): 69–76. doi:10.4103/glioma.glioma_17_22.